INFINIUM — Infinium Pharmachem Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapSucker Stock

Annual income statement for Infinium Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	705	991	1,142	1,356	1,557
Cost of Revenue
Gross Profit	157	224	337	314	368
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	662	897	995	1,198	1,398
Operating Profit	43	94	147	159	159
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	37.7	86.3	130	152	116
Provision for Income Taxes
Net Income After Taxes	27.3	66.9	98.2	115	78.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	27.2	61.1	94.9	113	81.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27.2	61.1	94.9	113	81.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.96	4.39	9.33	8.12	6.9